Quote:
Originally Posted by jeffreyn
And it seems they are wasting no time. Enterin are also currently running a trial of orally-administered ENT-01 for Parkinson's disease dementia (NCT03938922):
|
Thanks.
I hope that the trial gives encouraging results.
This is personal for me because an uncle of mine in NZ lived with PD for many years and towards the end had lost a lot of cognitive function.